CLASS II ONGOING Device recall · Reported 1 Feb 2023 · FDA Enforcement Report

Revogene Sars-CoV-2_IVD real-time Rt-pcr test intended recalled

Meridian Bioscience is recalling Revogene Sars-CoV-2_IVD real-time Rt-pcr test intended for the qualitative detection of, distributed nationwide in the US. The recall was initiated on 15 Dec 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: N/A Lot Numbers 410700P019, 410700P020, 410700P021, 410700P022, 410700P023, 410700P024, 410700P027
Quantity recalled92 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1008-2023
FDA event ID
91356
Recalling firm
Meridian Bioscience, Cincinnati, OH
Classification
Class II
Status
Ongoing
Recall initiated
15 Dec 2022
FDA classified
20 Jan 2023
Reported
1 Feb 2023
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Foreign Material

Timeline

15 Dec 2022Recall initiated by company
20 Jan 2023Classified by FDA+36 days
1 Feb 2023Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

Where it was distributed

US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.

Nationwide ArizonaCaliforniaIndianaKansasKentuckyLouisianaMichiganMinnesotaNorth CarolinaNew YorkOregonTexas

Questions about this recall

Why was it recalled?

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Which lots are affected?

UDI: N/A Lot Numbers 410700P019, 410700P020, 410700P021, 410700P022, 410700P023, 410700P024, 410700P027

Where was it sold?

US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Meridian Bioscience

All 15

Other Test Kits & Diagnostics recalls

All 2,663